142 related articles for article (PubMed ID: 10461764)
21. Pharmacology of lacidipine, a vascular-selective calcium antagonist.
Micheli D; Ratti E; Toson G; Gaviraghi G
J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S1-8. PubMed ID: 1725998
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic effects of a new 1,5-benzothiazepine calcium antagonist on stroke in salt-loaded stroke-prone spontaneously hypertensive rats.
Kikkawa K; Murata S; Iwasaki H; Toriumi W; Banno K; Nagao T
Arzneimittelforschung; 1992 Jun; 42(6):781-6. PubMed ID: 1418031
[TBL] [Abstract][Full Text] [Related]
23. Renal vascular responses in spontaneously hypertensive rats chronically treated with manidipine.
Muratani H; Takishita S; Kawazoe N; Tozawa M; Fukiyama K
Blood Press Suppl; 1992; 3():60-7. PubMed ID: 1343293
[TBL] [Abstract][Full Text] [Related]
24. Quantitative image analysis of choroid and retinal vasculature in SHR: a model of cerebrovascular hypertensive changes?
Tomassoni D; Mancinelli G; Mignini F; Sabbatini M; Amenta F
Clin Exp Hypertens; 2002; 24(7-8):741-52. PubMed ID: 12450248
[TBL] [Abstract][Full Text] [Related]
25. Influence of long-term treatment with the dihydropyridine-type calcium antagonist nicardipine on renal microanatomical changes in spontaneously hypertensive rats.
Amenta F; Abbate F; Cavallotti C; Ciriaco E; Ferrante F; Sabbatini M
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S333-4. PubMed ID: 9072416
[TBL] [Abstract][Full Text] [Related]
26. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies.
Micheli D; Collodel A; Semeraro C; Gaviraghi G; Carpi C
J Cardiovasc Pharmacol; 1990 Apr; 15(4):666-75. PubMed ID: 1691398
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic effects of imidapril on cerebral lesions observed by magnetic resonance imaging in malignant stroke-prone spontaneously hypertensive rats.
Takahashi M; Fritz-Zieroth B; Ohta Y; Chikugo T
J Hypertens; 1994 Jul; 12(7):761-8. PubMed ID: 7963504
[TBL] [Abstract][Full Text] [Related]
28. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
Klimas J; Vaja V; Vercinska M; Kyselovic J; Krenek P
Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):279-88. PubMed ID: 22626243
[TBL] [Abstract][Full Text] [Related]
29. 1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats.
Napoli C; Salomone S; Godfraind T; Palinski W; Capuzzi DM; Palumbo G; D'Armiento FP; Donzelli R; de Nigris F; Capizzi RL; Mancini M; Gonnella JS; Bianchi A
Stroke; 1999 Sep; 30(9):1907-15. PubMed ID: 10471444
[TBL] [Abstract][Full Text] [Related]
30. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
Kanda A; Haruno A; Miyake H; Nagasaka M
J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
[TBL] [Abstract][Full Text] [Related]
31. Effect of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats.
Takakura S; Furuichi Y; Yamamoto T; Ogawa T; Satoh H; Mori J
Stroke; 1994 Mar; 25(3):677-82; discussion 682-3. PubMed ID: 8128525
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of idebenone (CV-2619), a novel compound, on vascular lesions in hypertensive rats.
Nagaoka A; Shino A; Kakihana M; Iwatsuka H
Jpn J Pharmacol; 1984 Nov; 36(3):291-9. PubMed ID: 6521074
[TBL] [Abstract][Full Text] [Related]
33. Renal hemodynamics and sodium excretion in stroke-prone spontaneously hypertensive rats.
Nagaoka A; Kakihana M; Suno M; Hamajo K
Am J Physiol; 1981 Sep; 241(3):F244-9. PubMed ID: 7282927
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of the calcium antagonist NKY-722 against renal and arterial injuries in Dahl salt-sensitive rats.
Shirahase H; Uehara Y; Wada K; Shimaji H; Ishimitsu T; Hashizume Y; Kanda M; Nakamura S
J Hypertens; 1994 Feb; 12(2):137-44. PubMed ID: 8021464
[TBL] [Abstract][Full Text] [Related]
35. Lacidipine: experimental evidence of vasculoprotective properties.
Cristofori P; Micheli D; Terron A; Gaviraghi G
J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S90-3. PubMed ID: 7609515
[TBL] [Abstract][Full Text] [Related]
36. Changes in the gastric vascular network of malignant stroke-prone spontaneously hypertensive rats (M-SHRSP) after administration of the calcium antagonist manidipine.
Chiba A; Ohta Y; Suzuki T; Nakanishi H; Chichibu S
Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):151-60. PubMed ID: 9667069
[TBL] [Abstract][Full Text] [Related]
37. Beneficial effects of TDN-345, a novel Ca2+ antagonist, on ischemic brain injury and cerebral glucose metabolism in experimental animal models with cerebrovascular lesions.
Nakayama T; Nagisa Y; Imamoto T; Nagai Y
Brain Res; 1997 Jul; 762(1-2):203-10. PubMed ID: 9262174
[TBL] [Abstract][Full Text] [Related]
38. Preventative and therapeutic effects of AE0047 on renal injury in stroke-prone spontaneously hypertensive rats.
Hayashi K; Koyama M; Kido H; Egi Y; Kubo Y; Shinyama H; Iwamoto M; Nakamura N; Kagitani Y
Clin Exp Pharmacol Physiol; 1997 Nov; 24(11):831-40. PubMed ID: 9363365
[TBL] [Abstract][Full Text] [Related]
39. Functional reduction and associated cellular rearrangement in SHRSP rat basilar arteries are affected by salt load and calcium antagonist treatment.
Arribas SM; Costa R; Salomone S; Morel N; Godfraind T; McGrath JC
J Cereb Blood Flow Metab; 1999 May; 19(5):517-27. PubMed ID: 10326719
[TBL] [Abstract][Full Text] [Related]
40. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.
Stier CT; Adler LA; Levine S; Chander PN
J Hypertens Suppl; 1993 Apr; 11(3):S37-42. PubMed ID: 8315518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
